abstract |
The present invention relates to a Bordetella pertussis (B. pertussis), and the treatment composition, a vaccine, a means and a method for prevention. More particularly, the present invention relates to a three-step approach involving the removal of non-essential vaccine components, the use of detoxified mutants at non-denatured gene levels, and the addition of virulence factors. |